Miller Richard A Md insider trades
Miller Richard A Md has filed 22 Form 4s with the SEC that we hold, for Corvus Pharmaceuticals, Inc. (CRVS) (President and CEO, Director) and Bolt Biotherapeutics, Inc. (BOLT) (Director). Across all of them we count 18 purchases worth $1.3M and 0 sales worth $0 reported on Form 4. In the last 12 months: 2 purchases ($83.5K) and 0 sales ($0). The largest single trade was a purchase of 577,634 shares of Corvus Pharmaceuticals, Inc. worth $999.3K, dated 2024-05-06. The first filing on our record is dated 2021-08-23 and the latest 2026-05-20.
Corvus Pharmaceuticals, Inc. (CRVS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-20 | P, purchase reported on Form 4 | 10,000 | $19.3K | 2021-08-23 |
| 2022-03-15 | P, purchase reported on Form 4 | 25,000 | $36.8K | 2022-03-17 |
| 2022-03-17 | P, purchase reported on Form 4 | 5,000 | $8.0K | 2022-03-17 |
| 2022-03-31 | P, purchase reported on Form 4 | 15,000 | $24.6K | 2022-04-01 |
| 2022-06-02 | P, purchase reported on Form 4 | 4,830 | $4.7K | 2022-06-06 |
| 2022-06-02 | P, purchase reported on Form 4 | 170 | $165 | 2022-06-06 |
| 2022-06-06 | P, purchase reported on Form 4 | 890 | $899 | 2022-06-06 |
| 2022-06-24 | P, purchase reported on Form 4 | 5,000 | $5.2K | 2022-06-28 |
| 2022-06-27 | P, purchase reported on Form 4 | 5,000 | $5.0K | 2022-06-28 |
| 2022-09-20 | P, purchase reported on Form 4 | 2,700 | $2.2K | 2022-09-20 |
| 2022-09-20 | P, purchase reported on Form 4 | 5,000 | $4.1K | 2022-09-20 |
| 2022-09-20 | P, purchase reported on Form 4 | 12,300 | $10.0K | 2022-09-20 |
| 2022-09-28 | P, purchase reported on Form 4 | 25,000 | $19.0K | 2022-09-28 |
| 2022-12-13 | P, purchase reported on Form 4 | 50,000 | $37.0K | 2022-12-15 |
| 2022-12-14 | P, purchase reported on Form 4 | 10,000 | $7.8K | 2022-12-15 |
| 2024-05-06 | P, purchase reported on Form 4 | 577,634 | $999.3K | 2024-05-07 |
| 2026-05-18 | P, purchase reported on Form 4 | 5,000 | $60.2K | 2026-05-20 |
| 2026-05-18 | P, purchase reported on Form 4 | 1,932 | $23.2K | 2026-05-20 |
Bolt Biotherapeutics, Inc. (BOLT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1031847) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms